Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc.
AVIR
Valuace
70
Růst
0
Zdraví
75
Cena
$ 3.29
Dnes
--0.04 (-1.16%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.3B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-47%
ROA
-43%
PE
-3
PS
0
Cena 1R
2-4
⌀ Cena
3.21
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
05-03-2026
Poslední dividenda

Profil

Atea Pharmaceuticals, Inc., biofarmaceutická společnost v klinickém stadiu, se zaměřovala na objevování, vývoj a komercializaci antivirových terapií pro pacienty trpící virovými infekcemi. Jeho hlavním produktem je AT- 527, kandidát na antivirovou léčbu, který je v klinické studii fáze II pro léčbu pacientů s COVID-19. Společnost také vyvíjí AT-752, kandidát na perorální purinový nukleosidový proléčivý přípravek, který dokončil klinickou studii fáze Ia pro léčbu horečky dengue; AT-777, inhibitor NS5A; AT-787, kombinaci perorálních, pangenotypových fixních dávek AT-527 a AT-777 pro léčbu virové infekce hepatitidy C (HCV); a AT-281, farmaceuticky přijatelnou sůl pro léčbu nebo prevenci virové infekce RNA, včetně horečky dengue, žluté horečka, virus zika a virová infekce způsobená koronaviridae, stejně jako Ruzasvir, zkoušený perorální pangenotypový inhibitor NS5A k léčbě chronické infekce HCV. Má licenční smlouvu se společností Merck & Co, Inc. na vývoj a komercializaci ruzasviru pro léčbu HCV. Atea Pharmaceuticals, Inc. byla založena v roce 2012 a sídlí v Bostonu v Massachusetts.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
56
Založení
2020-10-30
Adresa
125 Summer Street
CEO
Jean-Pierre Sommadossi

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 20252024202320222021202020192018
Total Revenues0.000.000.000.000.00351,367.0048,633.000.000.00
Cost of Revenues5,963.00416.0083,367.0070,090.000.000.000.000.000.00
Gross Profit-5,963.00-416.00-83,367.00-70,090.000.00351,367.0048,633.000.000.00
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues0.000.000.000.000.000.000.000.000.000.00
Cost of Revenues104.000.002,419.003,440.00104.0019,923.00104.00104.00104.00104.00
Gross Profit-104.000.00-2,419.00-3,440.00-104.00-19,923.00-104.00-104.00-104.00-104.00
Operating Income TTM 20252024202320222021202020192018
R&D Expenses0.000.000.00132,843.0081,936.00167,205.0038,023.0010,170.006,675.00
Selling General & Admin Expenses0.000.000.0049,919.0048,714.0045,785.0021,640.004,438.002,802.00
Depreciation & Amortization416.00416.00416.00416.00260.0029.0019.0017.0017.00
Total Operating Expenses174,924.00180,887.00109,583.0094,072.00130,650.00212,990.0059,663.0014,608.009,477.00
Operating Income-180,887.00-180,887.00-192,950.00-164,162.00-130,650.00138,377.00-11,030.00-14,608.00-9,477.00
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.000.000.000.000.000.000.000.0035,045.0028,181.00
Selling General & Admin Expenses0.000.000.000.000.000.000.000.0011,424.0012,604.00
Depreciation & Amortization104.00104.00104.00104.00104.00104.00104.00104.00104.00104.00
Total Operating Expenses54,830.0045,567.0038,926.0035,601.0038,922.0017,279.0046,812.0069,702.0046,469.0040,785.00
Operating Income-54,934.00-45,567.00-41,345.00-39,041.00-39,026.00-37,202.00-46,916.00-69,806.00-46,573.00-40,785.00
Net Income TTM 20252024202320222021202020192018
Interest Income12,662.0016,376.0025,490.0029,224.0011,151.00213.0083.00574.00413.00
Interest Expense0.000.000.000.0011,151.000.000.000.000.00
Other Expense16,376.0016,376.0025,490.0029,224.0011,151.00213.0083.00574.00413.00
IBT-164,511.00-164,511.00-167,460.00-134,938.00-119,499.00138,590.00-10,947.00-14,034.00-9,064.00
Income Tax Expense-6,162.00-6,162.00925.001,018.00-3,590.0017,400.00-83.00-574.00413.00
Net Income-158,349.00-158,349.00-168,385.00-135,956.00-115,909.00121,190.00-10,864.00-13,460.00-9,064.00
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income3,299.000.004,391.004,972.005,708.006,277.006,637.006,868.007,758.007,864.00
Interest Expense0.000.000.000.000.000.000.000.000.000.00
Other Expense3,299.003,714.004,391.004,972.005,708.006,277.006,637.006,868.007,758.007,864.00
IBT-51,635.00-41,853.00-36,954.00-34,069.00-33,318.00-30,925.00-40,279.00-62,938.00-38,815.00-32,921.00
Income Tax Expense-6,768.00196.00207.00203.00225.00226.00243.00231.00349.00221.00
Net Income-44,867.00-42,049.00-37,161.00-34,272.00-33,543.00-31,151.00-40,522.00-63,169.00-39,164.00-33,142.00
Per Share Data TTM 20252024202320222021202020192018
EPS$0.00$0.00$0.00$-1.63$-5.37$1.46$-0.50$-0.28$-0.19
EPS Diluted$0.00$0.00$0.00$-1.63$-5.37$1.37$-0.50$-0.28$-0.19
Shares Outstanding78,126.8081,495.3584,264.7283,389.7521,592.4482,820.0421,592.4447,292.5247,292.52
Diluted Shares Outstanding78,126.8081,495.3584,264.7283,389.7521,592.4488,249.2421,592.4447,292.5247,292.52
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.47$-0.40
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.47$-0.40
Shares Outstanding78,126.8079,052.1583,747.3485,159.2584,463.0684,422.0084,253.7083,916.1983,435.5183,399.77
Diluted Shares Outstanding78,126.8079,052.1583,747.3485,159.2584,463.0684,422.0084,253.7083,916.1983,435.5183,399.77
Current Assets TTM 2024202320222021202020192018
Cash And Equivalents243,394.0064,696.00143,823.00646,709.00764,375.00850,117.0021,661.0034,492.00
Short Term Investments258,820.00390,025.00434,283.00458,249.000.000.000.000.00
Total Cash & ST Investments502,214.00454,721.00578,106.00646,709.00764,375.00850,117.0021,661.0034,492.00
Accounts Receivable0.000.000.000.000.005,815.000.000.00
Inventory0.000.000.000.000.000.000.000.00
Other Current Assets4,155.007,634.0012,349.0014,213.008,028.007,545.000.00206.00
Total Current Assets506,369.00462,355.00590,455.00660,922.00772,403.00863,477.0021,910.0034,698.00
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents77,344.0087,721.00119,394.0064,696.0098,463.00243,394.00160,910.00143,823.00137,886.00213,700.00
Short Term Investments251,965.00291,992.00306,042.00390,025.00384,350.00258,820.00380,581.00434,283.00457,240.00394,362.00
Total Cash & ST Investments329,309.00379,713.00425,436.00454,721.00482,813.00502,214.00541,491.00578,106.00595,126.00608,062.00
Accounts Receivable0.000.000.000.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.000.000.000.00
Other Current Assets6,829.005,891.008,272.007,634.004,093.004,155.007,273.0012,349.008,190.0012,764.00
Total Current Assets336,138.00385,604.00433,708.00462,355.00486,906.00506,369.00548,764.00590,455.00603,316.00620,826.00
Long-Term Assets TTM 2024202320222021202020192018
Net Property, Plant & Equipment2,619.002,116.003,117.004,094.0023.0048.0041.0056.00
Goodwill0.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.00
Long-Term Investments0.000.000.000.000.000.000.000.00
Other Long-Term Assets1,396.00197.001,396.001,692.00466.00107.00122.00107.00
Total Long-Term Assets4,015.002,313.004,513.005,786.00489.00155.00163.00163.00
Total Assets510,384.00464,668.00594,968.00666,708.00772,892.00863,632.0022,073.0034,861.00
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment1,350.001,607.001,862.002,116.002,368.002,619.002,869.003,117.003,363.003,608.00
Goodwill0.000.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.000.000.00
Long-Term Investments0.000.000.000.000.000.000.000.000.00198.00
Other Long-Term Assets5,475.004,394.004,394.00197.001,683.001,396.001,396.001,396.001,396.001,396.00
Total Long-Term Assets6,825.006,001.006,256.002,313.004,051.004,015.004,265.004,513.004,759.005,202.00
Total Assets342,963.00391,605.00439,964.00464,668.00490,957.00510,384.00553,029.00594,968.00608,075.00626,028.00
Current Liabilities TTM 2024202320222021202020192018
Accounts Payable5,470.004,458.004,252.002,551.004,534.0060.00548.00391.00
Short-Term Debt780.00800.00760.00721.000.000.000.000.00
Other Current Liabilities20,369.0013,345.0027,364.0015,206.0052,349.0014,368.001,887.001,369.00
Current Liabilities26,619.0018,603.0032,376.0018,478.0056,883.00315,795.002,435.001,760.00
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable3,515.008,844.007,387.004,458.005,785.005,470.0021,137.004,252.00395.003,962.00
Short-Term Debt832.00821.00811.00800.00790.00780.00769.00760.001,500.001,480.00
Other Current Liabilities15,828.0010,454.0013,549.0013,345.0012,414.0014,319.0019,405.0027,364.0011,381.0010,694.00
Current Liabilities20,175.0020,119.0021,747.0018,603.0025,190.0026,619.0041,311.0032,376.0018,893.0016,159.00
Long-Term Liabilities TTM 2024202320222021202020192018
Long-Term Debt1,245.00842.001,642.002,403.000.000.000.000.00
Capital Leases1,245.001,642.002,402.003,124.000.000.000.000.00
Def. Tax Liability0.000.000.000.000.000.000.000.00
Total Liabilities33,914.0025,801.0039,776.0026,136.0062,815.00315,831.0071,644.0071,022.00
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt213.00425.00634.00842.001,045.001,245.001,445.001,642.001,835.002,026.00
Capital Leases1,045.001,246.001,445.001,642.001,835.001,245.002,214.001,642.002,585.002,766.00
Def. Tax Liability0.000.000.000.000.000.000.000.000.000.00
Total Liabilities27,183.0027,189.0028,880.0025,801.0032,436.0033,914.0048,658.0039,776.0026,345.0023,679.00
Total Common Equity TTM 2024202320222021202020192018
Common Stock84.0084.0083.0083.0083.0082.0010.0010.00
Retained Earnings-299,526.00-364,220.00-195,835.00-59,879.0056,030.00-65,160.00-54,213.00-40,179.00
Comprehensive Income-280.00233.00207.00-684.000.00-863,632.000.000.00
Total Common Equity476,470.00438,867.00555,192.00640,572.00710,077.00547,801.00-49,571.00-36,161.00
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock78.0081.0085.0084.0084.0084.0084.0083.0083.0083.00
Retained Earnings-477,702.00-435,653.00-398,492.00-364,220.00-330,677.00-299,526.00-259,004.00-195,835.00-156,671.00-123,529.00
Comprehensive Income238.0037.00118.00233.00641.00-280.00-181.00207.00-262.00-310.00
Total Common Equity315,780.00364,416.00411,084.00438,867.00458,521.00476,470.00504,371.00555,192.00581,730.00602,349.00
Other TTM 2024202320222021202020192018
Total Debt2,025.001,642.002,402.003,124.000.000.000.000.00
Book Value476,470.00438,867.00555,192.00640,572.00710,077.00547,801.00-49,571.00-36,161.00
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.000.000.000.000.000.000.000.000.000.00
Book Value315,780.00364,416.00411,084.00438,867.00458,521.00476,470.00504,371.00555,192.00581,730.00602,349.00
Cash Flow From Operating Activities TTM 20252024202320222021202020192018
Net Income-175,997.00-158,349.00-168,385.00-135,956.00-115,909.00121,190.00-10,947.00-14,034.00-9,064.00
Depreciation & Amortization416.00416.00416.00416.00260.0029.0019.0017.0017.00
Stock-Based Compensation49,846.0020,720.0051,767.0049,428.0046,718.0039,621.007,457.00624.00414.00
Change Working Capital19,417.0016,482.00-7,476.0016,163.00-46,586.00-247,845.00300,205.00579.00725.00
Change In Accounts Receivable0.000.000.000.000.000.00-5,815.000.000.00
Change In Accounts Payable1,508.008,487.00206.001,701.00-1,983.0010,289.00-488.00157.00-90.00
Change In Inventories0.000.000.000.000.000.005,141.000.000.00
Other Non-cash Items55,297.00-4,944.00-11,821.0033,113.00-5,465.000.000.000.000.00
Cash from Operations-121,492.000.000.00-85,395.00-120,982.00-87,005.00296,734.00-12,814.00-7,908.00
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-44,867.00-42,049.00-37,161.00-34,272.00-33,543.00-31,151.00-40,522.00-63,169.00-39,164.00-33,142.00
Depreciation & Amortization104.00104.00104.00104.00104.00104.00104.00104.00104.00104.00
Stock-Based Compensation4,585.004,517.004,667.006,951.0014,297.0012,164.0012,720.0012,586.0012,157.0012,383.00
Change Working Capital19,119.00-1,872.00841.00-1,606.00-8,542.00-1,556.00-11,480.0014,102.009,414.007,381.00
Change In Accounts Receivable0.000.000.000.000.000.000.000.000.000.00
Change In Accounts Payable9,430.00-5,329.001,457.002,929.00-1,327.00315.00-15,667.0016,885.003,857.00-3,567.00
Change In Inventories0.000.000.000.000.000.000.000.000.000.00
Other Non-cash Items-808.00-1,075.00-1,321.00-1,740.00-2,713.00-2,596.00-3,024.00-3,488.004,163.0033,142.00
Cash from Operations0.000.000.000.000.000.000.000.00-21,834.00-17,591.00
Cash Flow From Investing Activities TTM 20252024202320222021202020192018
Capital Expenditure0.000.000.000.00-1,943.00-4.00-26.00-2.00-12.00
Acquisitions0.000.000.000.000.000.000.000.000.00
Investments-426,978.00-281,939.00-461,177.00-562,362.00-545,352.000.000.000.000.00
Sales of Investment577,724.00470,732.00517,282.00602,665.0091,885.000.000.000.000.00
Other Investing Activities181,457.260.000.000.000.000.000.000.000.00
Cash from Investing150,746.000.000.0040,303.00-455,410.00-4.00-26.00-2.00-12.00
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure0.000.000.000.000.000.000.000.000.000.00
Acquisitions0.000.000.000.000.000.000.000.000.000.00
Investments-43,791.00-14,780.00-100,730.00-122,638.00-58,475.00-228,242.00-7,264.00-167,196.00-47,230.00-205,288.00
Sales of Investment90,383.0056,083.00116,020.00208,246.0055,105.00106,229.00131,950.00223,998.0075,001.00146,775.00
Other Investing Activities0.000.000.000.000.000.000.000.0027.77-58.51
Cash from Investing0.000.000.000.000.000.000.000.0027,771.00-58,513.00
Cash Flow From Financing Activities TTM 20252024202320222021202020192018
Debt Repaid0.000.000.000.000.000.000.000.000.00
Debt Issued-741.001,642.00-760.00-722.003,124.000.000.000.000.00
Issuance of Common Stock242.000.000.00257.00230.001,465.00317,632.000.00124.00
Repurchase of Common Stock0.00-25,519.000.000.000.000.000.000.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.00
Other Financing Activities150.090.000.00257.00140.000.00214,116.00-15.0027,359.00
Cash from Financing242.000.000.00257.00370.001,465.00531,748.00-15.0027,483.00
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.000.000.000.000.000.000.000.000.000.00
Debt Issued1,045.00-201.00-199.00-197.00-193.00-190.00-189.00-188.00-183.00-181.00
Issuance of Common Stock0.000.000.000.000.000.000.000.000.0092.00
Repurchase of Common Stock0.00-11,426.00-14,093.000.000.000.000.000.000.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.000.00
Other Financing Activities0.000.000.000.000.000.000.000.000.0092.00
Cash from Financing0.000.000.000.000.000.000.000.000.0092.00
Cash position TTM 20252024202320222021202020192018
Net Change in Cash29,496.0031,017.00-79,127.00-44,835.00-576,022.00-85,544.00828,456.00-12,831.0019,563.00
Closing Cash Balance243,394.0095,713.0064,696.00143,823.00188,658.00764,680.00850,224.0021,768.0034,599.00
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash18,369.00-10,377.00-31,673.0054,698.00-33,767.00-144,931.0082,484.0017,087.005,937.00-76,012.00
Closing Cash Balance95,713.0077,344.0087,721.00119,394.0064,696.0098,463.00243,394.00160,910.00143,823.00137,886.00
Free Cash Flow TTM 20252024202320222021202020192018
Free Cash Flow-121,492.00-132,031.00-135,499.00-85,395.00-122,925.00-87,009.00296,708.00-12,816.00-7,920.00
Real Free Cash Flow-171,338.00-152,751.00-187,266.00-134,823.00-169,643.00-126,630.00289,251.00-13,440.00-8,334.00
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-28,223.00-40,375.00-32,870.00-30,563.00-30,397.00-23,035.00-42,202.00-39,865.00-21,834.00-17,591.00
Real Free Cash Flow-32,808.00-44,892.00-37,537.00-37,514.00-44,694.00-35,199.00-54,922.00-52,451.00-33,991.00-29,974.00
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-2.8-15.3-1.4
P/S0449.4
P/B1.40.25.2
P/FCF-2.9-3-1.5
Market cap$0.3$0.4
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0.3 %0.2 %0 %
Debt to Income-0.7 %0.8 %0 %
Debt to Free cash flow-0.7 %-4487.1 %0 %
Interest expense percentage0 %0.5 %44.7 %
Current ratio16.7 18.4 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-50.1 %-9.9 %0 %
ROA-46.2 %-14.8 %0 %
CapEx to Revenue0 %0.1 %0 %
RaD to Revenue0 %1158.6 %0 %
ROEM0.0 1069589.6

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin0 %32.3 %68.7 %
Operating margin0 %-1563.3 %35.5 %
Net margin0 %-1359 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding79.1 mil 78.0 mil
Employee count0.1 tis 0.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader